ArticleBioinformatics (Oxford, England)2025
mastR: an R package for automated identification of tissue-specific gene signatures in multi-group differential expression analysis.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ABCC9/SUR2 has a Complex Expression Pattern in Human Brain Gliovascular Unit Cells, Including Astrocytes.Journal of molecular neuroscience : MN · 2026Article
- Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer.Nature genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivationBiomarker discovery is important and offers insight into potential underlying mechanisms of disease. While existing biomarker identification methods primarily focus on single cell RNA sequencing (scRNA-seq) data, there remains a need for automated methods designed for labeled bulk RNA-seq data from sorted cell populations or experiments. Current methods require curation of results or statistical thresholds and may not account for tissue background expression. Here we bridge these limitations with an automated marker identification method for labeled bulk RNA-seq data that explicitly considers background expressions.
resultsWe developed mastR, a novel tool for accurate marker identification using transcriptomic data. It leverages robust statistical pipelines like edgeR and limma to perform pairwise comparisons between groups, and aggregates results using rank-product-based permutation test. A signal-to-noise ratio approach is implemented to minimize background signals. We assessed the performance of mastR-derived NK cell signatures against published curated signatures and found that the mastR-derived signature performs as well, if not better than the published signatures. We further demonstrated the utility of mastR on simulated scRNA-seq data and in comparison with Seurat in terms of marker selection performance. AVAILABILITY AND IMPLEMENTATION: mastR is freely available from https://bioconductor.org/packages/release/bioc/html/mastR.html. A vignette and guide are available at https://davislaboratory.github.io/mastR. All statistical analyses were carried out using R (version ≥4.3.0) and Bioconductor (version ≥3.17).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.